2-propanol has been researched along with latanoprost in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (21.43) | 18.2507 |
2000's | 39 (69.64) | 29.6817 |
2010's | 4 (7.14) | 24.3611 |
2020's | 1 (1.79) | 2.80 |
Authors | Studies |
---|---|
Resul, B; Selén, G; Sjöquist, B; Stjernschantz, J | 1 |
Abdel-Latif, AA; Ye, Z; Yousufzai, SY | 1 |
Albert, DM; Imesch, PD; Wallow, IH | 1 |
Resul, B; Selén, G; Stjernschantz, J | 1 |
Olsson, K; Stjernschantz, J; Wistrand, PJ | 1 |
Bito, LZ; Camras, CB; Toris, CB; Wang, YL; Zhan, GL | 1 |
Higginbotham, EJ; Pappas, RM; Pusin, S | 1 |
Abdel-Latif, AA; Yousufzai, SY | 1 |
Buckley, EG; Enyedi, LB; Freedman, SF | 1 |
Albert, DM; Grierson, I; Lee, WR | 1 |
Camras, CB; Eisenberg, DL | 1 |
Larsson, BS; Lindquist, NG; Stjernschantz, J | 1 |
Chen, YF; Hsieh, JW; Hung, PT; Wei, T | 1 |
Camras, CB; Neely, DG; Weiss, EL | 1 |
Napolitano, A; Prota, G; Selen, G; Stjernschantz, J; Vincensi, MR | 1 |
Cunningham, ET; Gaynor, BD; Stamper, RL | 1 |
Hu, DN; Lake, S; Ocklind, A; Stjernschantz, J; Wentzel, P | 1 |
Appleton, P; Goldsmith, H; Grierson, I; Hochgesand, D; Pfeiffer, N; Winkgen-Böhres, A | 1 |
Angert, M; Hewitt, EG; Jones, HL; Lindsey, JD; Weinreb, RN | 1 |
Hara, T | 1 |
Angert, M; Lindsey, JD; Wang, N; Weinreb, RN | 1 |
Andrew, R; Bergamini, MV; Davis, AA; Dickerson, J; Landry, T; Mallick, S; Netland, PA; Robertson, SM; Silver, L; Sullivan, EK; Weiner, A | 1 |
Abe, K; Chiba, T; Furuichi, M; Iijima, H; Kashiwagi, K; Kogure, S; Shibuya, T; Tsukahara, S | 1 |
Haik, BG; McLean, IW; Sivak-Callcott, JA; Tsai, JC; Zhang, J | 1 |
Hara, T; Inagaki, Y; Kumagai, K; Otaka, I; Saegusa, K; Shimoyama, M | 1 |
Iizuka, Y; Kanai, N; Kashiwagi, K; Suzuki, M; Tanaka, Y; Tsuchida, T; Tsukahara, S | 1 |
Cheng, CY; Chiang, SC; Chiu, AW; Chou, JC; Hsu, WM; Liu, CJ; Liu, JH | 1 |
Albert, DM; Drago, F; Hu, DN; Stjernschantz, JW; Wistrand, PJ | 1 |
Appleton, P; Cracknell, KP; Grierson, I; Pfeiffer, N | 1 |
Arranz-Márquez, E; Lucea-Suescun, P; Teus, MA | 1 |
Bergh, K; Stjernschantz, J; Wentzel, P | 1 |
Bergh, K; Niemelä, P; Stjernschantz, J; Wallin, O; Wentzel, P | 1 |
Appleton, P; Goldsmith, H; Grierson, I; Hochgesand, D; Pfeiffer, N; Winkgen, A | 1 |
Abdel-Latif, AA; Ansari, HR; Davis, AM; Kaddour-Djebbar, I | 1 |
Tesser, PM | 1 |
Fröhlich, SJ; Kampik, A; Mueller, AJ | 1 |
Appleton, P; Cracknell, KP; Grierson, I; Hogg, P; Pfeiffer, N | 1 |
Goto, W; Hara, H; Kageyama, M; Matsugi, T; Matsumura, Y; Mori, N; Nakajima, T | 1 |
Abdel-Latif, AA; Ansari, HR; Kaddour-Djebbar, I | 1 |
Alm, A; McDermott, J; Schoenfelder, J | 1 |
Arranz-Marquez, E; Gil, R; Mendez, MC; Saornil, MA; Teus, MA | 1 |
Albert, DM; Damico, CM; Fisher, MR; Gangnon, RE; Gleiser, J; Green, WR; Grossniklaus, HE; Zimbric, ML | 1 |
Abdel-Latif, AA; Akhtar, RA; Ansari, HR; Kaddour-Djebbar, I | 1 |
Iveković, R; Korsić, J; Mandić, Z; Masnec-Paskvalin, S; Novak-Laus, K; Zorić-Geber, M | 1 |
Hara, T; Inoue, J; Inoue, K; Matsuo, H; Tomita, G; Wakakura, M | 1 |
Hasegawa, Y; Hirano, K; Ishibashi, T; Kanaide, H; Niiro, N; Nishimura, J | 1 |
Cracknell, KP; Grierson, I; Hogg, P | 1 |
Cracknell, KP; Farnell, DJ; Grierson, I | 1 |
Arranz-Marquez, E; Teus, MA | 1 |
Martin, J; Schwartz, B; Takamoto, T | 1 |
Albert, DM; Darjatmoko, S; Gangnon, RE; Green, WR; Grossniklaus, HE; Kulkarni, AD | 1 |
Baycu, C; Kara, S; Sahin, A; Yildirim, N | 1 |
Sihota, R | 1 |
Borghi, V; Carreiro, ST; Chiroli, V; Chong, WK; Gale, DC; Impagnatiello, F; Krauss, AH; Ongini, E; Prasanna, G; Toris, CB | 1 |
Anderson, MG; Dutca, LM; Galor, A; Garvin, MK; Robles, V; Rudd, D | 1 |
Agarwal, P; Goldsmith, JA; Sayegh, RR; Smith, SD | 1 |
5 review(s) available for 2-propanol and latanoprost
Article | Year |
---|---|
The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation.
Topics: Cell Count; Cell Division; Eye Color; Humans; Iris; Iris Diseases; Latanoprost; Melanins; Pigment Epithelium of Eye; Pigmentation Disorders; Prostaglandins F, Synthetic | 1997 |
A preliminary risk-benefit assessment of latanoprost and unoprostone in open-angle glaucoma and ocular hypertension.
Topics: Dinoprost; Drug Administration Schedule; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Latanoprost; Ocular Hypertension; Pigment Epithelium of Eye; Prostaglandins F, Synthetic; Risk Assessment | 1999 |
Mechanism and clinical significance of prostaglandin-induced iris pigmentation.
Topics: Amides; Animals; Antihypertensive Agents; Bimatoprost; Cloprostenol; Dinoprost; Eye Color; Gene Expression Regulation; Humans; Iris; Iris Diseases; Latanoprost; Lipids; Melanocytes; Monophenol Monooxygenase; Pigmentation Disorders; Prostaglandins F, Synthetic; Receptors, Prostaglandin; Travoprost; Up-Regulation | 2002 |
Histology and fine structure of the iris and outflow system following latanoprost therapy.
Topics: Antihypertensive Agents; Eye Color; Glaucoma; Humans; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Melanins; Melanocytes; Pigmentation Disorders; Prostaglandins F, Synthetic; Trabecular Meshwork | 2002 |
An Indian perspective on primary angle closure and glaucoma.
Topics: Acute Disease; Anterior Chamber; Antihypertensive Agents; Chronic Disease; Cornea; Disease Progression; Drug Administration Schedule; Glaucoma, Angle-Closure; Humans; Incidence; India; Iris; Latanoprost; Ocular Hypertension; Ophthalmologic Surgical Procedures; Prevalence; Prostaglandins F, Synthetic; Timolol | 2011 |
11 trial(s) available for 2-propanol and latanoprost
Article | Year |
---|---|
The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color.
Topics: Adrenergic beta-Antagonists; Double-Blind Method; Europe; Eye Color; Glaucoma; Humans; Incidence; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Melanins; Melanosis; Ophthalmic Solutions; Prostaglandins F, Synthetic; Time Factors; Timolol; United States | 1997 |
The effectiveness of latanoprost for the treatment of pediatric glaucoma.
Topics: Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Infant; Intraocular Pressure; Iris; Latanoprost; Male; Ophthalmic Solutions; Pigment Epithelium of Eye; Prospective Studies; Prostaglandins F, Synthetic; Safety; Treatment Outcome | 1999 |
The fine structure of an iridectomy specimen from a patient with latanoprost-induced eye color change.
Topics: Aged; Cataract Extraction; Eye Color; Female; Humans; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Pigmentation Disorders; Prostaglandins F, Synthetic | 1999 |
Histological effects in the iris after 3 months of latanoprost therapy: the Mainz 1 study.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Biomarkers; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Immunoenzyme Techniques; Intraocular Pressure; Iris; Ki-67 Antigen; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Proliferating Cell Nuclear Antigen; Prostaglandins F, Synthetic; Single-Blind Method; Trabeculectomy | 2001 |
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cloprostenol; Double-Blind Method; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pigmentation Disorders; Prodrugs; Prostaglandins F, Synthetic; Safety; Timolol; Travoprost; Treatment Outcome | 2001 |
Iridial pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Eye Color; Female; Glaucoma; Humans; Incidence; Intraocular Pressure; Iris; Iris Diseases; Japan; Latanoprost; Male; Melanosis; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic | 2001 |
Use of latanoprost to reduce acute intraocular pressure rise following neodymium: Yag laser iridotomy.
Topics: Acute Disease; Aged; Aged, 80 and over; Antihypertensive Agents; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iris; Laser Therapy; Latanoprost; Male; Middle Aged; Ocular Hypertension; Pilocarpine; Premedication; Prostaglandins F, Synthetic; Safety; Tonometry, Ocular; Treatment Outcome; Visual Acuity | 2002 |
Fine structural evaluation of the iris after unilateral treatment with latanoprost in patients undergoing bilateral trabeculectomy (the Mainz II study).
Topics: Administration, Topical; Aged; Antihypertensive Agents; Double-Blind Method; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Iris; Latanoprost; Male; Melanins; Melanocytes; Middle Aged; Prostaglandins F, Synthetic; Trabeculectomy | 2003 |
A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Chemotherapy, Adjuvant; Drug Evaluation; Exfoliation Syndrome; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Latanoprost; Longitudinal Studies; Male; Middle Aged; Ophthalmic Solutions; Pigmentation Disorders; Prospective Studies; Prostaglandins F, Synthetic; Safety | 2004 |
[Use of antiglaucoma therapy to reduce acute intraocular pressure rise following neodymium: YAG laser iridotomy in angle-closure glaucoma patients].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Female; Glaucoma, Angle-Closure; Humans; Iris; Laser Therapy; Latanoprost; Male; Middle Aged; Miotics; Ocular Hypertension; Pilocarpine; Postoperative Complications; Prostaglandins F, Synthetic; Quinoxalines | 2006 |
Increase and decrease of measurements of iris density of glaucoma patients treated with latanoprost over 36 months.
Topics: Aged; Female; Follow-Up Studies; Glaucoma; Humans; Image Processing, Computer-Assisted; Iris; Latanoprost; Male; Middle Aged; Multivariate Analysis; Neuroprotective Agents; Prospective Studies; Prostaglandins F, Synthetic | 2008 |
40 other study(ies) available for 2-propanol and latanoprost
Article | Year |
---|---|
Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2 alpha analogue.
Topics: Administration, Topical; Animals; Aqueous Humor; Blood Platelets; Cats; Cattle; Cornea; Coronary Vessels; Corpus Luteum; Dinoprost; Female; Guinea Pigs; Ileum; In Vitro Techniques; Iris; Latanoprost; Macaca fascicularis; Male; Muscle, Smooth; Organ Specificity; Prostaglandins F, Synthetic; Rabbits; Regional Blood Flow; Swine; Vas Deferens | 1995 |
Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species.
Topics: Animals; Cats; Cattle; Ciliary Body; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprost; Dinoprostone; Dogs; Dose-Response Relationship, Drug; Humans; Indomethacin; Iris; Latanoprost; Macaca mulatta; Muscles; Prostaglandins; Prostaglandins F, Synthetic; Rabbits | 1996 |
Prostaglandin-induced iridial pigmentation in primates.
Topics: Administration, Topical; Animals; Dinoprost; Dinoprostone; Eye Color; Iris; Iris Diseases; Latanoprost; Macaca fascicularis; Melanosis; Ophthalmic Solutions; Pigment Epithelium of Eye; Prostaglandins; Prostaglandins F, Synthetic; Sympathectomy | 1997 |
Prostaglandin-induced iris color darkening. An experimental model.
Topics: Administration, Topical; Animals; Eye Color; Female; Ganglia, Sympathetic; Ganglionectomy; Hyperpigmentation; Iris; Latanoprost; Models, Biological; Ophthalmic Solutions; Photography; Prostaglandins F, Synthetic; Rabbits | 1998 |
Evidence of early change in iris color with latanoprost use.
Topics: Aged; Eye Color; Female; Humans; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Ocular Hypertension; Pigmentation Disorders; Prostaglandins F, Synthetic | 1998 |
Tyrosine kinase inhibitors suppress prostaglandin F2alpha-induced phosphoinositide hydrolysis, Ca2+ elevation and contraction in iris sphincter smooth muscle.
Topics: Animals; Calcium; Carbachol; Cardiotonic Agents; Cats; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genistein; Hydrolysis; Iris; Latanoprost; Muscle Contraction; Muscle, Smooth; Phosphatidylinositols; Prostaglandins F, Synthetic; Protein-Tyrosine Kinases; Vanadates | 1998 |
Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue.
Topics: Animals; Eye Color; Female; Iris; Latanoprost; Macaca fascicularis; Male; Melanins; Melanocytes; Methimazole; Prostaglandins F, Synthetic | 1999 |
Efficacy of latanoprost as an adjunct to medical therapy for residual angle-closure glaucoma after iridectomy.
Topics: Adjuvants, Pharmaceutic; Aged; Antihypertensive Agents; Female; Glaucoma, Angle-Closure; Humans; Iris; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Time Factors | 2000 |
Latanoprost-induced iris color darkening: a case report with long-term follow-up.
Topics: Antihypertensive Agents; Autonomic Nervous System Diseases; Cocaine; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Pigmentation Disorders; Prostaglandins F, Synthetic; Pupil; Sympathetic Nervous System | 2000 |
Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Female; Hyperpigmentation; Iris; Iris Diseases; Latanoprost; Macaca fascicularis; Melanins; Melanocytes; Monophenol Monooxygenase; Ophthalmic Solutions; Prostaglandins F, Synthetic | 2000 |
Presumed activation of herpetic keratouveitis after Argon laser peripheral iridotomy.
Topics: Acyclovir; Aged; Antiviral Agents; Chronic Disease; Glaucoma; Herpesvirus 1, Human; Humans; Intraocular Pressure; Iris; Keratitis, Herpetic; Laser Therapy; Latanoprost; Male; Prostaglandins F, Synthetic; Uveitis, Anterior; Virus Activation | 2000 |
Latanoprost-induced increase of tyrosinase transcription in iridial melanocytes.
Topics: Animals; Antihypertensive Agents; Blotting, Northern; Choroid; Female; In Situ Hybridization; Iris; Latanoprost; Macaca fascicularis; Male; Melanocytes; Monophenol Monooxygenase; Pigment Epithelium of Eye; Prostaglandins F, Synthetic; RNA, Messenger; Transcription, Genetic | 2000 |
Induction of tyrosinase gene transcription in human iris organ cultures exposed to latanoprost.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; DNA Primers; DNA Probes; Enzyme Induction; Eye Color; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Iris; Latanoprost; Middle Aged; Monophenol Monooxygenase; Organ Culture Techniques; Polymerase Chain Reaction; Prostaglandins F, Synthetic; RNA, Messenger; Tissue Donors; Transcription, Genetic | 2001 |
[Increased iris pigmentation after use of latanoprost in Japanese brown eyes].
Topics: Adult; Aged; Aged, 80 and over; Eye Color; Female; Glaucoma; Humans; Iris; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Pigmentation Disorders; Prostaglandins F, Synthetic | 2001 |
Latanoprost and matrix metalloproteinase-1 in human choroid organ cultures.
Topics: Adult; Aged; Aged, 80 and over; Blotting, Western; Choroid; Ciliary Body; Dinoprost; DNA Primers; DNA Probes; Humans; Immunoblotting; Iris; Latanoprost; Matrix Metalloproteinase 1; Middle Aged; Organ Culture Techniques; Polymerase Chain Reaction; Prostaglandins F, Synthetic; RNA, Messenger | 2001 |
Latanoprost-induced iris heterochromia and open-angle glaucoma: a clinicopathologic report.
Topics: Antihypertensive Agents; Diagnosis, Differential; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Melanosis; Middle Aged; Mitomycin; Prostaglandins F, Synthetic; Trabeculectomy | 2001 |
Simple and inexpensive software designed for the evaluation of color.
Topics: Antihypertensive Agents; Eye Color; Humans; Iris; Iris Diseases; Latanoprost; Pigmentation Disorders; Prostaglandins F, Synthetic; Software Design | 2002 |
Comparison between isopropyl unoprostone and latanoprost by prostaglandin E(2)induction, affinity to prostaglandin transporter, and intraocular metabolism.
Topics: Adult; Animals; Antihypertensive Agents; Antiporters; Aqueous Humor; Cattle; Culture Techniques; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; DNA-Binding Proteins; HeLa Cells; Humans; Indomethacin; Iris; Latanoprost; Organic Anion Transporters; Prostaglandins F, Synthetic | 2002 |
Incidence of iris colour change in latanoprost treated eyes.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cohort Studies; Erythrocytes; Eye Color; Female; Glaucoma; Humans; Iris; Latanoprost; Male; Middle Aged; Photography; Prospective Studies; Prostaglandins F, Synthetic | 2002 |
Production of prostaglandin e(2) by iridial melanocytes exposed to latanoprost acid, a prostaglandin F(2 alpha) analogue.
Topics: Aged; Aged, 80 and over; Animals; Cattle; Cells, Cultured; Dinoprostone; Female; Humans; Iris; Latanoprost; Male; Melanocytes; Middle Aged; Pigment Epithelium of Eye; Prostaglandins F, Synthetic; Thromboxane B2; Trabeculectomy | 2002 |
Transcription of prostanoid receptor genes and cyclooxygenase enzyme genes in cultivated human iridial melanocytes from eyes of different colours.
Topics: Aged; Aged, 80 and over; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Eye Color; Female; Humans; Iris; Isoenzymes; Latanoprost; Male; Melanocytes; Membrane Proteins; Middle Aged; Prostaglandin-Endoperoxide Synthases; Prostaglandins F, Synthetic; Receptors, Prostaglandin; Transcription, Genetic | 2003 |
Effects of prostaglandin F2alpha and latanoprost on phosphoinositide turnover, myosin light chain phosphorylation and contraction in cat iris sphincter.
Topics: Animals; Antihypertensive Agents; Cats; Dinoprost; Dose-Response Relationship, Drug; In Vitro Techniques; Intraocular Pressure; Iris; Latanoprost; Muscle Contraction; Muscle, Smooth; Myosin Light Chains; Myosin-Light-Chain Kinase; Phosphatidylinositols; Phosphorylation; Prostaglandins F, Synthetic | 2003 |
An iris coloboma preventing pigmentary glaucoma.
Topics: Coloboma; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Laser Therapy; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Trabeculectomy | 2003 |
[Relative contraindication of latanoprost in iris tumors with secondary glaucoma].
Topics: Adult; Antihypertensive Agents; Cell Transformation, Neoplastic; Contraindications; Disease Progression; Glaucoma; Humans; Intraocular Pressure; Iris; Iris Neoplasms; Latanoprost; Male; Melanoma; Prostaglandins F, Synthetic | 2003 |
Latanoprost-induced iris darkening: a morphometric study of human peripheral iridectomies.
Topics: Antihypertensive Agents; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iridectomy; Iris; Iris Diseases; Latanoprost; Melanins; Melanocytes; Melanosomes; Microscopy, Electron; Pigmentation Disorders; Prostaglandins F, Synthetic; Stromal Cells; Trabeculectomy | 2003 |
New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents.
Topics: Administration, Topical; Animals; Cats; Cell Line, Tumor; Dinoprost; Drug Evaluation, Preclinical; Forecasting; Intraocular Pressure; Iris; Latanoprost; Macaca fascicularis; Melanins; Mice; Miosis; Prostaglandins F; Prostaglandins F, Synthetic; Receptors, Prostaglandin | 2003 |
Effects of prostaglandin F2alpha, latanoprost and carbachol on phosphoinositide turnover, MAP kinases, myosin light chain phosphorylation and contraction and functional existence and expression of FP receptors in bovine iris sphincter.
Topics: Animals; Antihypertensive Agents; Carbachol; Cattle; Culture Techniques; Dinoprost; Dose-Response Relationship, Drug; Inositol Phosphates; Iris; Latanoprost; Mitogen-Activated Protein Kinases; Muscle Contraction; Muscle, Smooth; Myosin Light Chains; Phosphatidylinositols; Phosphorylation; Prostaglandins F, Synthetic; Receptors, Prostaglandin; Signal Transduction | 2004 |
Analysis of irises with a latanoprost-induced change in iris color.
Topics: Aged; Antihypertensive Agents; Biopsy; Exfoliation Syndrome; Eye Color; Female; Glaucoma, Open-Angle; Humans; Inclusion Bodies; Iris; Iris Diseases; Latanoprost; Male; Melanins; Melanocytes; Melanosis; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic | 2004 |
A study of iridectomy histopathologic features of latanoprost- and non-latanoprost-treated patients.
Topics: Antihypertensive Agents; Eye Color; Female; Glaucoma; Humans; Intraocular Pressure; Iridectomy; Iris; Latanoprost; Male; Melanins; Melanocytes; Melanosis; Prostaglandins F, Synthetic | 2004 |
Species differences in the effects of prostanoids on MAP kinase phosphorylation, myosin light chain phosphorylation and contraction in bovine and cat iris sphincter smooth muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cats; Cattle; Dinoprost; Dinoprostone; Extracellular Signal-Regulated MAP Kinases; Iris; Latanoprost; Muscle Contraction; Muscle, Smooth; Myosin Light Chains; Phosphorylation; Prostaglandins; Prostaglandins F, Synthetic; Species Specificity | 2005 |
[Adverse reaction after use of latanoprost in Japanese glaucoma patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Eyelashes; Eyelids; Female; Glaucoma; Humans; Iris; Latanoprost; Male; Middle Aged; Pigmentation Disorders; Prospective Studies; Prostaglandins F, Synthetic | 2006 |
Prostaglandin F2alpha, but not latanoprost, increases the Ca2+ sensitivity of the pig iris sphincter muscle.
Topics: Animals; Antihypertensive Agents; Calcium; Carbachol; Dinoprost; Enzyme Inhibitors; Intracellular Signaling Peptides and Proteins; Iris; Latanoprost; Muscle Contraction; Muscle, Smooth; Myosin Light Chains; Phosphorylation; Prostaglandins F, Synthetic; Protein Serine-Threonine Kinases; rho-Associated Kinases; Swine; Type C Phospholipases | 2006 |
Morphometric effects of long-term exposure to latanoprost.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iridectomy; Iris; Iris Diseases; Latanoprost; Male; Melanins; Melanocytes; Middle Aged; Pigmentation Disorders; Prostaglandins F, Synthetic | 2007 |
Monte Carlo simulation of latanoprost induced iris darkening.
Topics: Antihypertensive Agents; Computer Simulation; Dose-Response Relationship, Drug; Eye Color; Humans; Iris; Iris Diseases; Latanoprost; Melanins; Models, Biological; Monte Carlo Method; Pigmentation Disorders; Prostaglandins F, Synthetic | 2007 |
Iris morphology.
Topics: Antihypertensive Agents; Eye Color; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iridectomy; Iris; Iris Diseases; Latanoprost; Melanins; Melanocytes; Pigmentation Disorders; Prostaglandins F, Synthetic | 2008 |
A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides.
Topics: Antihypertensive Agents; Endothelium, Vascular; Fibroblasts; Glaucoma; Humans; Iridectomy; Iris; Iris Diseases; Latanoprost; Melanins; Melanocytes; Melanosis; Prostaglandins F, Synthetic | 2008 |
Latanoprost-induced changes in the iris and trabeculum: an electron-microscopic morphological study.
Topics: Aged; Antihypertensive Agents; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Iridectomy; Iris; Latanoprost; Male; Melanins; Microscopy, Electron, Transmission; Middle Aged; Prostaglandins F, Synthetic; Time Factors; Trabecular Meshwork; Trabeculectomy | 2010 |
Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Aqueous Humor; Cell Line; Ciliary Body; Cyclic GMP; Dinoprost; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Female; Glaucoma; Guanylate Cyclase; Intraocular Pressure; Iris; Latanoprost; Macaca fascicularis; Male; Nitric Oxide; Nitric Oxide Donors; Ocular Hypertension; Prostaglandins F, Synthetic; Rabbits; Rats; Tonometry, Ocular | 2011 |
Effects of sustained daily latanoprost application on anterior chamber anatomy and physiology in mice.
Topics: Animals; Anterior Chamber; Benzalkonium Compounds; Cornea; Delayed-Action Preparations; Intraocular Pressure; Iris; Latanoprost; Male; Matrix Metalloproteinases; Mice, Inbred C57BL; Pigmentation; Time Factors | 2018 |
Novel mechanism of decreased iris vasculature density after cosmetic iris implants.
Topics: Acetaminophen; Acetazolamide; Administration, Intravenous; Adult; Analgesics, Non-Narcotic; Carbonic Anhydrase Inhibitors; Humans; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Male; Mydriasis; Ophthalmic Solutions; Prostheses and Implants; Tomography, Optical Coherence | 2021 |